Hypertrophic cardiomyopathy guidelines released

New guidelines on hypertrophic cardiomyopathy (HCM) have been released by the CSANZ to reflect major advances in management that have taken place in the last five years.

The condition, which may cause ventricular fibrillation and sudden death after sport or exertion, is now thought to affect as many as one in 500 people, making it the commonest known cardiovascular genetic  disorder, according to the guideline authors.

They say the condition has a complex pathophysiology and affected individuals may have a benign, asymptomatic course or may develop serious